Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours
Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains...
Saved in:
Published in | BMC genomics Vol. 10; no. 1; p. 93 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
26.02.2009
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics.
In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found.
Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics. |
---|---|
AbstractList | Abstract Background Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. Results In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. Conclusion Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics. Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics. BACKGROUND: Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. RESULTS: In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. CONCLUSION: Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics. BACKGROUNDRecently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. RESULTSIn this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. CONCLUSIONGlobal gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics. Abstract Background Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. Results In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. Conclusion Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics. |
ArticleNumber | 93 |
Audience | Academic |
Author | Sun, Ruping Fu, Xuping Li, Yao Xie, Yi Mao, Yumin |
AuthorAffiliation | 1 State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, PR China |
AuthorAffiliation_xml | – name: 1 State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, PR China |
Author_xml | – sequence: 1 givenname: Ruping surname: Sun fullname: Sun, Ruping email: regularhand@gmail.com organization: State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, PR China. regularhand@gmail.com – sequence: 2 givenname: Xuping surname: Fu fullname: Fu, Xuping – sequence: 3 givenname: Yao surname: Li fullname: Li, Yao – sequence: 4 givenname: Yi surname: Xie fullname: Xie, Yi – sequence: 5 givenname: Yumin surname: Mao fullname: Mao, Yumin |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19245699$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kt9rnTAUx2V0rD-2572NwGCwB1uPUaMvg9uydRfKBt32HI7xaFM0cYmW9r9f3L10FTp8SDj55KNfzzmODow1FEVvITkFKIszyATEKRRZDElc8RfR0WPl4Mn-MDr2_jZJQJRp_io6hCrN8qKqjqLxsrc19qwjQ4zuR0fea2sYGuwfvPbM0R1hv6zNrKhhWM-mQaOI2ZaN84STviM2aOXs9bcNm9B1NHmmDbuZBzRsdNYHiNg0D3Z2_nX0sg0-erNfT6JfXz7_vPgaX32_3F5sruK6ADHFKufAoU0arHlbCpUKKoB4gipsFE-hhKJosM1yzlMFSiSYI9WQlzyrykrwk2i78zYWb-Xo9IDuQVrU8m_Buk6im7TqSYLgQiihVJBlNRdlhoAJNEhteIUqg-vTzjXO9UCNIjM57FfS9YnRN7KzdzItcp7zRXC-E9Ta_kewPlF2kEv35NI9CYmseJB82H-Fs79n8pMctFfU92jIzl4WIoGkLJfo73dghyGdNq0NTrXAcgNVDgXPSgjU6TNUeBoK3Qxj1upQX134uLoQmInupw5n7-X2x_WaPduxYSy8d9Q-Zg1Zlsl9Jt27p__4H78fVf4HhO3rag |
CitedBy_id | crossref_primary_10_3892_or_2015_4331 crossref_primary_10_1016_j_bbcan_2014_02_002 crossref_primary_10_12954_PI_12011 crossref_primary_10_1016_j_steroids_2010_11_003 crossref_primary_10_1186_s13148_015_0076_2 crossref_primary_10_1373_clinchem_2013_205450 crossref_primary_10_1373_clinchem_2010_157727 crossref_primary_10_1186_s12865_015_0134_8 crossref_primary_10_1016_j_ando_2014_09_001 crossref_primary_10_1210_me_2011_0099 crossref_primary_10_1186_1475_2867_10_15 crossref_primary_10_3389_fgene_2022_808950 crossref_primary_10_1093_abbs_gmq038 crossref_primary_10_1002_em_20645 crossref_primary_10_1089_dna_2011_1600 crossref_primary_10_3390_ijms140610822 crossref_primary_10_1128_IAI_00649_19 crossref_primary_10_1371_journal_pone_0020271 crossref_primary_10_1074_jbc_M111_335943 crossref_primary_10_1261_rna_1905910 crossref_primary_10_1371_journal_pone_0224071 crossref_primary_10_1093_nar_gkt680 crossref_primary_10_3390_ijms23116281 crossref_primary_10_1007_s11684_009_0055_0 crossref_primary_10_3382_ps_2013_03656 crossref_primary_10_3382_ps_pev289 crossref_primary_10_1039_c0mb00100g crossref_primary_10_1002_pros_23356 |
Cites_doi | 10.1091/mbc.02-02-0023. 10.1038/35090585 10.1593/neo.07112 10.1073/pnas.0510928103 10.1038/nature06174 10.1002/pros.20756 10.1186/1476-4598-5-24 10.1158/0008-5472.CAN-07-0533 10.1016/S0076-6879(06)11002-2 10.1093/bioinformatics/btl308 10.1200/JCO.2004.05.158 10.1158/0008-5472.CAN-06-4478 10.1016/j.cell.2004.12.038 10.1016/j.cell.2005.11.023 10.1016/j.bbrc.2006.11.080 10.1016/j.ccr.2006.01.013 10.1073/pnas.0304146101 10.1158/0008-5472.CAN-08-0144 10.1038/ng1536 10.1016/j.cell.2005.01.014 10.1038/sj.onc.1210809 10.1016/j.ccr.2005.10.001 10.1261/rna.634607 10.1038/nm733 10.1038/nrc1840 10.1038/msb4100089 10.1038/nature07228 10.1038/sj.leu.2404688 10.1038/nature03702 10.1126/science.1111443 10.1002/ijc.23693 10.1073/pnas.0511045103 10.1126/science.1121158 10.1126/science.1155390 10.1093/nar/gkl1032 10.1007/s00018-007-7054-6 10.1016/j.cell.2004.12.035 10.1073/pnas.0510565103 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2009 BioMed Central Ltd. Copyright © 2009 Sun et al; licensee BioMed Central Ltd. 2009 Sun et al; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2009 BioMed Central Ltd. – notice: Copyright © 2009 Sun et al; licensee BioMed Central Ltd. 2009 Sun et al; licensee BioMed Central Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISR 7X8 5PM DOA |
DOI | 10.1186/1471-2164-10-93 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale in Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1471-2164 |
EndPage | 93 |
ExternalDocumentID | oai_doaj_org_article_17377c7cc4534b3784a1a01daef6dac8 oai_biomedcentral_com_1471_2164_10_93 A195163481 10_1186_1471_2164_10_93 19245699 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- -A0 0R~ 23N 2VQ 2WC 2XV 3V. 4.4 53G 5VS 6J9 7X7 88E 8AO 8FE 8FH 8FI 8FJ AAFWJ AAHBH AAJSJ ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX AIXEN ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C1A C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IGS IHR INH INR IPNFZ ISR ITC KQ8 LK8 M1P M48 M7P M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX CITATION ABVAZ AFGXO AFNRJ 7X8 5PM |
ID | FETCH-LOGICAL-b617t-c53131f0dab3f87c27e61e30ac7e6c3218166daf45332c1c70a5aeb1583498973 |
IEDL.DBID | RPM |
ISSN | 1471-2164 |
IngestDate | Tue Oct 22 15:12:54 EDT 2024 Tue Sep 17 21:21:36 EDT 2024 Wed May 22 07:12:46 EDT 2024 Sat Oct 26 01:11:54 EDT 2024 Fri Feb 23 00:21:22 EST 2024 Fri Feb 02 04:38:50 EST 2024 Sat Sep 28 21:00:43 EDT 2024 Thu Sep 12 16:35:04 EDT 2024 Sat Sep 28 07:56:08 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b617t-c53131f0dab3f87c27e61e30ac7e6c3218166daf45332c1c70a5aeb1583498973 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653538/ |
PMID | 19245699 |
PQID | 67010887 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_17377c7cc4534b3784a1a01daef6dac8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2653538 biomedcentral_primary_oai_biomedcentral_com_1471_2164_10_93 proquest_miscellaneous_67010887 gale_infotracmisc_A195163481 gale_infotracacademiconefile_A195163481 gale_incontextgauss_ISR_A195163481 crossref_primary_10_1186_1471_2164_10_93 pubmed_primary_19245699 |
PublicationCentury | 2000 |
PublicationDate | 2009-02-26 |
PublicationDateYYYYMMDD | 2009-02-26 |
PublicationDate_xml | – month: 02 year: 2009 text: 2009-02-26 day: 26 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | BMC genomics |
PublicationTitleAlternate | BMC Genomics |
PublicationYear | 2009 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 16286247 - Cancer Cell. 2005 Nov;8(5):393-406 16495412 - Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4034-9 17141185 - Biochem Biophys Res Commun. 2007 Jan 19;352(3):733-8 17158157 - Nucleic Acids Res. 2007;35(1):152-64 14711987 - Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):811-6 17410184 - Leukemia. 2007 Jun;21(6):1198-203 11518967 - Nature. 2001 Aug 23;412(6849):822-6 16477010 - Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2746-51 15766527 - Cell. 2005 Mar 11;120(5):635-47 17891175 - Oncogene. 2008 Mar 13;27(12):1788-93 18566288 - Science. 2008 Jun 20;320(5883):1643-7 17415519 - Cell Mol Life Sci. 2007 Jul;64(14):1752-62 15766526 - Cell. 2005 Mar 11;120(5):623-34 18366025 - Prostate. 2008 Oct 1;68(14):1496-509 16308420 - Science. 2005 Dec 16;310(5755):1817-21 17237090 - Bioinformatics. 2007 Jan 15;23(2):e184-90 17652130 - RNA. 2007 Sep;13(9):1402-8 12058060 - Mol Biol Cell. 2002 Jun;13(6):1929-39 15944708 - Nature. 2005 Jun 9;435(7043):834-8 16337999 - Cell. 2005 Dec 16;123(6):1133-46 12118244 - Nat Med. 2002 Aug;8(8):816-24 16939783 - Methods Enzymol. 2006;411:14-34 15806104 - Nat Genet. 2005 May;37(5):495-500 16557279 - Nat Rev Cancer. 2006 Apr;6(4):259-69 16784538 - Mol Cancer. 2006;5:24 16969338 - Mol Syst Biol. 2006;2:46 18649363 - Int J Cancer. 2008 Oct 1;123(7):1616-22 15652477 - Cell. 2005 Jan 14;120(1):15-20 17898713 - Nature. 2007 Oct 11;449(7163):682-8 16141059 - Science. 2005 Sep 2;309(5740):1514-8 18676839 - Cancer Res. 2008 Aug 1;68(15):6162-70 17616669 - Cancer Res. 2007 Jul 1;67(13):6130-5 15254046 - J Clin Oncol. 2004 Jul 15;22(14):2790-9 16461460 - Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 17575136 - Cancer Res. 2007 Jun 15;67(12):5699-707 18668040 - Nature. 2008 Sep 4;455(7209):58-63 16473279 - Cancer Cell. 2006 Feb;9(2):121-32 17356713 - Neoplasia. 2007 Feb;9(2):166-80 M Selbach (1977_CR14) 2008; 455 SM Dhanasekaran (1977_CR17) 2001; 412 MD Mattie (1977_CR6) 2006; 5 R Sandberg (1977_CR23) 2008; 320 1977_CR39 1977_CR37 P Sood (1977_CR13) 2006; 103 YP Yu (1977_CR15) 2004; 22 KP Porkka (1977_CR7) 2007; 67 Z Yu (1977_CR22) 2007; 35 X Chen (1977_CR36) 2002; 13 SM Johnson (1977_CR10) 2005; 120 AL Richardson (1977_CR33) 2006; 9 Q Jing (1977_CR27) 2005; 120 W Li (1977_CR30) 2008; 123 S Varambally (1977_CR18) 2005; 8 Q Cui (1977_CR26) 2006; 2 DR Rhodes (1977_CR38) 2007; 9 DG Beer (1977_CR34) 2002; 8 L Wu (1977_CR1) 2006; 103 M Ozen (1977_CR8) 2008; 27 1977_CR42 1977_CR41 1977_CR40 J Lapointe (1977_CR16) 2004; 101 Q Cui (1977_CR25) 2007; 352 E Wang (1977_CR32) 2007; 64 BP Lewis (1977_CR2) 2005; 120 TS Davison (1977_CR31) 2006; 411 A Andersson (1977_CR35) 2007; 21 S Ambs (1977_CR19) 2008; 68 A Krek (1977_CR9) 2005; 37 S Landais (1977_CR28) 2007; 67 KK Farh (1977_CR11) 2005; 310 A Esquela-Kerscher (1977_CR3) 2006; 6 MJ Moore (1977_CR20) 2005; 309 O Rokhlenko (1977_CR43) 2007; 23 A Stark (1977_CR12) 2005; 123 J Lu (1977_CR5) 2005; 435 H Liang (1977_CR24) 2007; 13 L Ma (1977_CR29) 2007; 449 S Volinia (1977_CR4) 2006; 103 M Jiang (1977_CR21) 2008; 68 |
References_xml | – volume: 13 start-page: 1929 issue: 6 year: 2002 ident: 1977_CR36 publication-title: Mol Biol Cell doi: 10.1091/mbc.02-02-0023. contributor: fullname: X Chen – volume: 412 start-page: 822 issue: 6849 year: 2001 ident: 1977_CR17 publication-title: Nature doi: 10.1038/35090585 contributor: fullname: SM Dhanasekaran – volume: 9 start-page: 166 issue: 2 year: 2007 ident: 1977_CR38 publication-title: Neoplasia doi: 10.1593/neo.07112 contributor: fullname: DR Rhodes – volume: 103 start-page: 4034 issue: 11 year: 2006 ident: 1977_CR1 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0510928103 contributor: fullname: L Wu – volume: 449 start-page: 682 issue: 7163 year: 2007 ident: 1977_CR29 publication-title: Nature doi: 10.1038/nature06174 contributor: fullname: L Ma – volume: 68 start-page: 1496 issue: 14 year: 2008 ident: 1977_CR21 publication-title: Prostate doi: 10.1002/pros.20756 contributor: fullname: M Jiang – volume: 5 start-page: 24 year: 2006 ident: 1977_CR6 publication-title: Mol Cancer doi: 10.1186/1476-4598-5-24 contributor: fullname: MD Mattie – volume: 67 start-page: 6130 issue: 13 year: 2007 ident: 1977_CR7 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-0533 contributor: fullname: KP Porkka – ident: 1977_CR41 – volume: 411 start-page: 14 year: 2006 ident: 1977_CR31 publication-title: Methods Enzymol doi: 10.1016/S0076-6879(06)11002-2 contributor: fullname: TS Davison – volume: 23 start-page: e184 issue: 2 year: 2007 ident: 1977_CR43 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btl308 contributor: fullname: O Rokhlenko – volume: 22 start-page: 2790 issue: 14 year: 2004 ident: 1977_CR15 publication-title: J Clin Oncol doi: 10.1200/JCO.2004.05.158 contributor: fullname: YP Yu – volume: 67 start-page: 5699 issue: 12 year: 2007 ident: 1977_CR28 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-4478 contributor: fullname: S Landais – volume: 120 start-page: 623 issue: 5 year: 2005 ident: 1977_CR27 publication-title: Cell doi: 10.1016/j.cell.2004.12.038 contributor: fullname: Q Jing – ident: 1977_CR37 – volume: 123 start-page: 1133 issue: 6 year: 2005 ident: 1977_CR12 publication-title: Cell doi: 10.1016/j.cell.2005.11.023 contributor: fullname: A Stark – volume: 352 start-page: 733 issue: 3 year: 2007 ident: 1977_CR25 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2006.11.080 contributor: fullname: Q Cui – volume: 9 start-page: 121 issue: 2 year: 2006 ident: 1977_CR33 publication-title: Cancer Cell doi: 10.1016/j.ccr.2006.01.013 contributor: fullname: AL Richardson – volume: 101 start-page: 811 issue: 3 year: 2004 ident: 1977_CR16 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0304146101 contributor: fullname: J Lapointe – volume: 68 start-page: 6162 issue: 15 year: 2008 ident: 1977_CR19 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-0144 contributor: fullname: S Ambs – volume: 37 start-page: 495 issue: 5 year: 2005 ident: 1977_CR9 publication-title: Nat Genet doi: 10.1038/ng1536 contributor: fullname: A Krek – ident: 1977_CR39 – volume: 120 start-page: 635 issue: 5 year: 2005 ident: 1977_CR10 publication-title: Cell doi: 10.1016/j.cell.2005.01.014 contributor: fullname: SM Johnson – volume: 27 start-page: 1788 issue: 12 year: 2008 ident: 1977_CR8 publication-title: Oncogene doi: 10.1038/sj.onc.1210809 contributor: fullname: M Ozen – volume: 8 start-page: 393 issue: 5 year: 2005 ident: 1977_CR18 publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.10.001 contributor: fullname: S Varambally – volume: 13 start-page: 1402 issue: 9 year: 2007 ident: 1977_CR24 publication-title: Rna doi: 10.1261/rna.634607 contributor: fullname: H Liang – volume: 8 start-page: 816 issue: 8 year: 2002 ident: 1977_CR34 publication-title: Nat Med doi: 10.1038/nm733 contributor: fullname: DG Beer – volume: 6 start-page: 259 issue: 4 year: 2006 ident: 1977_CR3 publication-title: Nat Rev Cancer doi: 10.1038/nrc1840 contributor: fullname: A Esquela-Kerscher – volume: 2 start-page: 46 year: 2006 ident: 1977_CR26 publication-title: Mol Syst Biol doi: 10.1038/msb4100089 contributor: fullname: Q Cui – volume: 455 start-page: 58 issue: 7209 year: 2008 ident: 1977_CR14 publication-title: Nature doi: 10.1038/nature07228 contributor: fullname: M Selbach – volume: 21 start-page: 1198 issue: 6 year: 2007 ident: 1977_CR35 publication-title: Leukemia doi: 10.1038/sj.leu.2404688 contributor: fullname: A Andersson – volume: 435 start-page: 834 issue: 7043 year: 2005 ident: 1977_CR5 publication-title: Nature doi: 10.1038/nature03702 contributor: fullname: J Lu – volume: 309 start-page: 1514 issue: 5740 year: 2005 ident: 1977_CR20 publication-title: Science doi: 10.1126/science.1111443 contributor: fullname: MJ Moore – volume: 123 start-page: 1616 issue: 7 year: 2008 ident: 1977_CR30 publication-title: Int J Cancer doi: 10.1002/ijc.23693 contributor: fullname: W Li – ident: 1977_CR40 – ident: 1977_CR42 – volume: 103 start-page: 2746 issue: 8 year: 2006 ident: 1977_CR13 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0511045103 contributor: fullname: P Sood – volume: 310 start-page: 1817 issue: 5755 year: 2005 ident: 1977_CR11 publication-title: Science doi: 10.1126/science.1121158 contributor: fullname: KK Farh – volume: 320 start-page: 1643 issue: 5883 year: 2008 ident: 1977_CR23 publication-title: Science doi: 10.1126/science.1155390 contributor: fullname: R Sandberg – volume: 35 start-page: 152 issue: 1 year: 2007 ident: 1977_CR22 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkl1032 contributor: fullname: Z Yu – volume: 64 start-page: 1752 issue: 14 year: 2007 ident: 1977_CR32 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-007-7054-6 contributor: fullname: E Wang – volume: 120 start-page: 15 issue: 1 year: 2005 ident: 1977_CR2 publication-title: Cell doi: 10.1016/j.cell.2004.12.035 contributor: fullname: BP Lewis – volume: 103 start-page: 2257 issue: 7 year: 2006 ident: 1977_CR4 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0510565103 contributor: fullname: S Volinia |
SSID | ssj0017825 |
Score | 2.141252 |
Snippet | Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer... Abstract Background Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA... BACKGROUNDRecently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling... BACKGROUND: Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling... Abstract Background Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA... |
SourceID | doaj pubmedcentral biomedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 93 |
SubjectTerms | 3' Untranslated Regions - genetics Androgens - metabolism DNA microarrays Down-Regulation Gene expression Gene Expression Profiling Gene Expression Regulation, Neoplastic Genetic aspects Humans Male MicroRNAs - genetics Oligonucleotide Array Sequence Analysis Physiological aspects Prostate cancer Prostatic Neoplasms - genetics RNA RNA, Messenger - genetics Up-Regulation |
SummonAdditionalLinks | – databaseName: BioMed Central dbid: RBZ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCIlLVd6hLVgICS4RcezYjnraIqqCRA8LlSouluMHVKLZVZNI8O-ZSdKHW26cdrWejex887I885mQN1E3OkoRch15kwvsAbbaizwKZyumCluNjcJfjuThsfh8Up1ckUXfOMFnWr5n4D7zErJ69Bg1v0vu4XXJaIPL_e-XBwYQ6KqxkWgWnll8_vGAG53tv5KANPL23_bO18JTWjp5LRYdbJHNOYmkiwn1h-ROaB-R-9O1kn8ek_VE5E9BNwINv-dS15bamYCEIm0TqB18ekDWU9tgPwjAT1eRrod-JAOnZ1irtzxa0KlavKOnLR2v9KNrbBWBJJX2wxnMpXtCjg8-fvtwmM83K-QNZCx97sDyOIuFtw2PWrlSBckCL6yDL45j2JfS2yggGSwdc4iZBa9eaS5qXSv-lGy0qzY8J5RFW0tXehEh0MXgawdJJLfKyyJE2O1lZC953WY9sWgY5LVOR8DEDIJlECwDu5OaZ-TdBTiXfxy3LVreFt1H8JLnjz-AMpnZDA1TXCmnnIOViYYrLSyzBfMW5uqt0xl5jdAbZMZosfTmhx26znz6ujQLBlonsW85I29nobiCiTs7dzLAC0EyrURyJ5EE03XJ8KsLDTM4hPVubVgNnZEK9sng_zPybNK3q9XXeFRd1xlRiSYm605H2tOfI294KSsO8e3FfyGyTR5MB2plXsodstGfD2EX8rK-eTla5F88sDWG priority: 500 providerName: BioMedCentral – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yIHgR18_qqkEEvZRtmjQfeHqKyyq4h9WFvYU0TXTB7XvYFtb_3pmmb31hD148tTRpaWZ-ycyQmV8IeR11q6MUodSRt6XAGmCnO1FG4V3DVOWauVD4y4k8PhOfz5vznaO-MCcs0QMnwR0yxZXyynvRcNFypYVjrmKdC1F2zqcy38psg6ll_wDsXjPXFSlW1hARLKQ-TMvD62e4AuF-c1bo_jOzTzON_83Fesda5ZmUO6bp6B65u_iUdJXGsk9uhf4-uZ1Omfz9gGwSrz8FqAQarpbM1566hY-EIosToBCuHSi6o67F8hBAA11HupnGmRucXmLq3unJiqbk8YFe9HQ-4Y9usHIEfFY6TpfwL8NDcnb08duH43I5aKFswYEZSw8TkbNYda7lUStfqyBZ4JXzcOM5egEShB1BBbz2zKMKHSzyjebCaKP4I7LXr_vwhFAWnZG-7kQEuxdDZzz4lNypTlagsIoV5F0mbrtJpBoWaa7zFphxFpVlUVkWghXDC_J2q5zrF-coRsubXd-j8rLvzw8AXHYBl_0XuAryClVvkSijx0yc724aBvvp66ldMfBNJZYxF-TN0imu4ce9WwobQCDIrZX1PMh6wkz2WfPLLcIsNmH6Wx_W02ClgrAZzEFBHie8_R29wZ1rYwqiMiRm485b-osfM414LRsO5u7p_xDUM3InbbPVZS0PyN74awrPwVsb2xfzxPwDHJ09uQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9UwFA86EXwRv61ODSLoS7Vt0iRFRK7imIJ7mF7YW0jTZA629nrbwvbfe06beRe3B596aXJLcj5yziHn_A4hr7yqlRfcpcqzOuVYA2xUw1PPrSlzmZlyKhT-vid2l_zbQXmwaQcUCNhfGdphP6nl-vjt6e-zj6DwHyaFV-JdDgdsWoDfj2dKxa6TGwWicmEeH99cKYApLKdSozA54Pxc8YF_at-PI5M1IftfPr8vGLA4ufKCtdq5Q24HN5MuZrm4S6659h65OTeePLtPVjPUPwXpcdSdhmTYlpoAUUIR2AkIBM8GeN9QU2PFCAgI7TxdjcMEF05PMJtvf29B53zynh61dGr6R1dYTAJuLB3GE1hL_4Asd778_Lybht4LaQ0-zZBa0E2W-6wxNfNK2kI6kTuWGQs_LEPHQIjGeA7uYmFzi1w1cO6XivFKVZI9JFtt17rHhObeVMIWDfdgCr1rKgtuJjOyEZnzEA8m5H1Ebr2acTY0Il_HI6CEGpmlkVka4peKJeTNOXP-_nEKbJS4PPUTMi_6_vSiWx_qoKg6l0xKK62FnfGaScVNbrK8MbDWxliVkJfIeo3YGS0m5xyase_11x_7epGDuyqwsjkhr8Mk38HCrQm1DkAQhNuKZm5HM0G5bTT84lzCNA5hRlzrurHXQkIkDRYiIY9medvsvsLL7KpKiIwkMdp3PNIe_ZqQxQtRMrCAT_6fpk_Jrfl-rUgLsU22hvXonoGbNtTPJ_X7A0JAOgs priority: 102 providerName: Scholars Portal |
Title | Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19245699 https://search.proquest.com/docview/67010887 http://dx.doi.org/10.1186/1471-2164-10-93 https://pubmed.ncbi.nlm.nih.gov/PMC2653538 https://doaj.org/article/17377c7cc4534b3784a1a01daef6dac8 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBZtx2Avo_tZr10mxmB7cRNZsiSzp6S0dIOEkq0Q9iJkWeoCjROaBLb_fidZ2Sr6thcnRLKRfN_p7qK7Twh9cLKWjjObS0frnPkaYC0bljtmdEnEQJehUHg84ZfX7OusnO2hclcLE5L2TT0_bW8Xp-38Z8itXC1Mf5cn1r8anxW8pKCo_X20DwDdhehx6wBMXhk5fIjkfQKrb15AUOAXnCocm1P5zT5P9pqUuN8mlikQ-D9cpu_ZqTSH8p5RujhET6M3iYfdqJ-hPds-R4-78yV_v0CrjtEfA0gstr9izmuLdWQiwZ6_CfAHnw2IuMG69oUhgAO8dHi13QRWcLzwSXvTyRB3aeNrPG9xONsPr3zNCHireLNdwFjWL9H1xfn3s8s8HrGQ1-C6bHIDKkiJGzS6pk4KUwjLiaUDbeCLod7-c95ox8ArLAwxXngalvdSUlbJStBX6KBdtvYIYeJ0xU3RMAcWz9mmMuBNUi0aPrAOwr4MfU5et1p1dBrKE1ynLaBrystNebkpCFMqmqFPO-H8vTHEL5I_7DrywkueH35Y3t2oCCNFBBXCCGNgZqymQjJN9IA0GsbaaCMz9N6LXnmKjNbn4Nzo7XqtvnybqiEBr5T7AuYMfYyd3BIGbnQsaYAX4lm1kp4nSU_QYZM0v9shTPkmn_jW2uV2rbiAgBkMQYZed3j7N_sI4wyJBInJvNMW0KdAIB71581_33mMnnS7akVe8BN0sLnb2rfgnG3qHqjkTPTQo9H55GraC39xwHXMJFynox-9oKx_AAY_QVY |
link.rule.ids | 108,230,315,730,783,787,867,888,2109,2228,24332,24951,27938,27939,31734,33759,53806,53808,76148,76149 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGEIIXvj8Cg1kICV7SxnFiO-KpTEwdrBUaG9qb5Tj2qFjTak0k4K_nnDgwsyd4StVzKl_9O9-dfPczQq-sKIVlmYmFpWWcuR5gJaostplWOeGJyrtG4dmcTU-yD6f56RbKh16Yrmhfl4tRfb4c1YuvXW3leqnHQ53Y-NNsL2U5BUMdX0PX4ZGwIUn3hwfg9HLP4kMEGxPYf-MU0gK35RTdxTmFO-5zdK9Bk_t54Js6Cv-rG_UlTxVWUV5yS_t30JdBob4a5duobcqR_vkX1-M_a3wX3faBKp704ntoy9T30Y3-6sofD9C6vywAA_4MNt99OW2NlSc5wY4aCqANzwrQU2FVup4TgBheWbxum45wHC9dPeDRfIL7ivQNXtS4uzYQr107CgTCuGmXMJfNQ3Sy__54bxr72xviEqKiJtZg3ZTYpFIltYLrlBtGDE2Uhg-autCCsUrZDALOVBPtcKHAc-SCZoUoOH2EtutVbZ4gTKwqmE6rzIIztaYqNASqVPGKJcZCRhmht8E6ynXP1CEdd3YoATOWDhDSAUJCBlTQCL0ZVv33i11qJNjVoe8cKoLf775YXZxJv16ScMq55lqDZllJucgUUQmpFMy1UlpE6KXDlHTsG7Ur7zlT7WYjDz4fyQmBgJe53ugIvfaD7AomrpXvloA_xBF2BSN3gpGwPehAvDtAVzqRq6mrzardSMYhFwcfE6HHPZD_aO_tI0I8gHigdygB4Hbc5B6oT__7zV10c3o8O5SHB_OPz9Ct_vAujUm-g7abi9Y8hxiwKV90Fv8LQGNd7Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgCMQL3x-BwSyEBC9pkzixHfFUBtUGrJoGk6a9WI5jj4o1jdZEAv56zo4LNXvbU6P6Uvnqn3138t3vEHpteMUNzXXMDani3NYAS17nscmVLFKWyMIVCh_M6N5x_umkONlo9eWS9lU1HzXni1Ez_-5yK9uFGq_zxMaHB7sZLQhs1HFbm_F1dAMeE74O1P0FAhi-wjP5pJyOUziD4wxCA3vslK55Tmmv_Czla1Dofh7YJ0fjf_mw3rBWYSblhmma3kWna6WGjJQfo76rRur3f3yPV9L6HrrjHVY8GUTuo2u6eYBuDi0sfz1E7dA0AAMONdY_fVptg6UnO8GWIgogDp81oKjGsrK1JwA1vDS47TtHPI4XNi_waDbBQ2b6Cs8b7NoH4taWpYBDjLt-AXNZPULH04_fdvdi38UhrsA76mIFu5ykJqllRQxnKmOappokUsGDItbFoLSWJgfHM1OpsviQYEEKTvKSl4w8RlvNstFPEU6NLKnK6tyAUTW6LhU4rESymibaQGQZoXfBWop2YOwQlkM7HIHtLCwohAWFgEioJBF6u175vy-6EInTy6LvLTKC33dfLC_OhF8zkTLCmGJKgWZ5RRjPZSqTtJYw11oqHqFXFlfCsnA0Ns3nTParldj_eiQmKTi-1NZIR-iNFzJLmLiSvmoC_hBL3BVIbgeScEyoYHhnDV9hh2xuXaOX_UpQBjE52JoIPRnA_E97v0cixAKYB3qHIwBex1Huwfrsym_uoFuHH6biy_7s83N0e7jDy-KMbqOt7qLXL8AV7KqXbtP_AQMEYG8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+gene+expression+analysis+reveals+reduced+abundance+of+putative+microRNA+targets+in+human+prostate+tumours&rft.jtitle=BMC+genomics&rft.au=Sun%2C+Ruping&rft.au=Fu%2C+Xuping&rft.au=Li%2C+Yao&rft.au=Xie%2C+Yi&rft.date=2009-02-26&rft.issn=1471-2164&rft.eissn=1471-2164&rft.volume=10&rft.issue=1&rft_id=info:doi/10.1186%2F1471-2164-10-93&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_1471_2164_10_93 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2164&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2164&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2164&client=summon |